Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Additive Benefit of the Urine Lipoarabinomannan Test to Current TB Diagnostics Among HIV+ Adults in Panama City, Panama

NCT02911740 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02911740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Additive Benefit of the Urine Lipoarabinomannan Test to Current TB Diagnostics Among HIV+ Adults in Panama City, Panama
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2017
Completion date
August 31, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

histoplasmosis, hiv, tuberculosis